ArticleBMJ (Clinical research ed.)2015

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.

Neena S Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.